1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
    Growth Shares

    These 3 Aussie stocks could skyrocket and stay there for decades

    | James Mickleboro

    Let's see what sets these stocks apart from the rest.

    Read more »

    A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
    Healthcare Shares

    After a horror month should you buy the dip on CSL shares?

    | Bernd Struben

    A leading expert delivers his verdict on CSL shares.

    Read more »

    An accountant gleefully makes corrections and calculations on his abacus with a pile of papers next to him.
    How to invest

    If I invest $500 a month into ASX shares, what would I have in 10 years?

    | James Mickleboro

    Let's do the maths so you don't have to.

    Read more »

    asx share price secret represented by woman holing hands up to ear through hole in wall
    Healthcare Shares

    After falling 22% in August, is this ASX 100 star the best share to buy today?

    | Leigh Gant

    Profits are up, shares are down. Is this market darling primed for a rebound?

    Read more »

    a group of young people dance together with their hands in the air, moving to music as they celebrate ASX 200 shares rising today.
    Broker Notes

    5 ASX 200 shares set to rise by 30% to 45% over the next 12 months: Experts

    | Bronwyn Allen

    If you're looking for opportunities during this traditionally weaker month for the market, here are some expert tips.

    Read more »

    A woman in her late 30s holds her hands out either side with the palms up as if indicating she doesn't know the answer to a question. She has a quizzical look on her face.
    Opinions

    Should you buy Wisetech and these other falling ASX 200 blue-chip shares?

    | Bronwyn Allen

    These ASX 200 shares fell by 10% or more post-results last month... and they've kept declining ever since.

    Read more »

    Woman flexes muscles after donating blood.
    Healthcare Shares

    Why is the CSL share price falling today?

    | Bronwyn Allen

    The ASX 200 healthcare darling is in the red on Tuesday. Here's why.

    Read more »

    5 mini houses on a pile of coins.
    Share Market News

    Property isn't the only game in town. Here's where else Aussies are building wealth

    | Leigh Gant

    Property’s power is real, but it’s not the whole story. See where else wealth is being created today.

    Read more »

    A man looking at his laptop and thinking.
    Share Market News

    5 things to watch on the ASX 200 on Tuesday

    | James Mickleboro

    Here's what to expect on the local market today.

    Read more »

    Middle age caucasian man smiling confident drinking coffee at home.
    Blue Chip Shares

    Buy, hold, sell: CSL, Telstra, and Wesfarmers shares

    | James Mickleboro

    Analysts have given their verdict on these shares.

    Read more »

    Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
    Broker Notes

    JP Morgan cuts price target on CSL shares. Are they still a buy?

    | Laura Stewart

    The ASX 200 healthcare stock fell 17% following its FY25 result.

    Read more »

    A fresh-faced young woman holds an Australian flag aloft above her head as she smiles widely.
    How to invest

    Why you should buy ASX shares instead of US stocks right now

    | James Mickleboro

    Australia could be the way to go for investors according to Bell Potter.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note